Monday newspaper round-up: AstraZeneca, North Sea jobs, Glaxo...
14th Jan 2013 06:56
The Science Minister has lobbied the NHS to increase its use of an AstraZeneca heart medicine, amid mounting political concern about the drugs company's commitment to British jobs. David Willetts has urged health officials to accelerate the uptake of Brilique, a blood thinner used to treat patients
Read moreCourt upholds legal ruling on AstraZeneca 'Crestor' patent
17th Dec 2012 11:13
On Friday December 14th, the Court of Appeals for the Federal Circuit announced that it had upheld the District Court in Delaware's finding that biopharmaceutical business AstraZeneca's substance patent protecting Crestor is valid and enforceable. The ruling follows legal wranglings dating back fi
Read moreLondon close: 'Fiscal cliff' concerns keep markets under pressure
13th Dec 2012 16:45
- Boehner says White House not serious about 'cliff' - Stocks shrug off Fed stimulus - Centamin plummets after mine suspension Stocks markets across Europe took a breather on Thursday, following a strong performance over the last month, as investors digested stimulus plans by the Federal Reserve an
Read moreFTSE 100 movers: Wood Group falls as update comes in mixed
13th Dec 2012 15:48
Energy services giant Wood Group fell after it reported mixed trading in its Upstream division and despite saying it expects to deliver good growth this year, with overall conditions in energy markets remaining 'favourable'. AstraZeneca fell after revealing that its experimental drug for rheumatoi
Read moreWednesday broker round-up UPDATE
12th Dec 2012 07:25
AMEC: Credit Suisse reduces target price from 1300p to 1250p reiterating an outperform rating. Anglo American: Barclays upgrades to equal-weight with a target price of 1970p. Ashtead Group: Barclays raises target price from 352p to 434p and reiterates an overweight rating. ASOS: HSBC raises targe
Read moreEU Court upholds 52.5m euro fine against AstraZeneca Group
6th Dec 2012 11:18
Global biopharmaceutical group AstraZeneca (AZ) has lost an appeal over a 52.5m euro fine relating to the way that its subsidiaries AstraZeneca AB and AstraZeneca Plc marketed an ulcer-treating drug. The case, which dates back to 2005 and has been subject to two appeals, surrounds the way that the
Read moreMonday broker round-up UPDATE
3rd Dec 2012 07:16
ARM Holdings: Exane BNP Paribas upgrades from neutral to buy. Ashtead Group: Bank of America starts with a target price of 460p and a buy recommendation. AstraZaneca: Berenberg raises target price from 3080p to 3100p; hold recommendation kept. Balfour Beatty: Investec reduces target price from 21
Read moreDiageo CEO reduces stake further
22nd Nov 2012 16:17
The Chief Executive Officer of Diageo, the FTSE 100 drinks giant, has sold another slice of his stake in the company, reducing his holding to 729,582 shares. Paul Walsh, who was appointed to the role of CEO in 2000, traded in 20,000 shares for 1,850.00p each, worth a total of £370,000. The trans
Read moreAstraZeneca CEO builds up stake
21st Nov 2012 16:34
The Chief Executive Officer of drugs giant AstraZeneca has purchased 3,500 shares in the company, taking his stake in the group to 141,716 shares. Pascal Soriot, who took up his current role just last month, bought the shares at 2,825p each for a total of £98,875. 53-year-old Soriot joined Astra
Read moreLondon close: Stocks finish flat as Eurogroup meets
12th Nov 2012 17:00
- Eyes turn to Eurogroup meeting - Greece approves 2013 budget - Japanese GDP decline worse than feared Concerns about Greece and a worse-than-expected contraction in Japan meant that it was a rather subdued day on the UK stock market on Monday, with the FTSE 100 broadly unchanged by the close. "E
Read moreLondon midday: Stocks rise but markets cautious ahead of Eurogroup
12th Nov 2012 11:36
- Greece approves 2013 budget - Japanese GDP worse than expected - Markets await Eurogroup meeting this afternoon UK stocks were continuing to trade slightly higher on Monday morning after Greece approved its 2013 budget late last night, however, gains were only modest as caution sets in ahead of
Read moreLondon open: Stocks rise as Greece approves budget
12th Nov 2012 08:30
- Greece approves 2013 budget - Japanese GDP worse than expected - Miners fall but Polymetal bucks the trend UK stocks were making gains on Monday morning, rebounding after a 1.7 per cent fall the previous week, as the markets' concerns about the Greek economy eased temporarily. Greece's parliamen
Read moreLondon pre-open: Strong start expected on Greek hopes
12th Nov 2012 07:35
London's FTSE 100 is expected to open positively on Monday morning following tough week which saw the benchmark index lose 1.7 per cent of its value. City sources predict that the Footsie will open with moderate gains from Friday's closing price of 5,770. Newsflow from Greece has lifted sentiment
Read morePositive results for Astra's constipation treatment
12th Nov 2012 07:07
Drugs giant AstraZeneca has announced a clutch of positive test results relating to its naloxegol product, a treatment for opioid-induced constipation (OIC). The results come from two Phase III trials and one safety extension trial in patients with non-cancer related pain and OIC. The Phase III KO
Read moreLondon midday: Stocks lifted by UK GDP and Japanese speculation
25th Oct 2012 11:36
- UK GDP beats expectations in Q3 - Japan to boost asset purchases, says newspaper - Unilever and AstraZeneca provide a lift after Q3 updates After a cautious start, the FTSE 100 was registering decent gains by Thursday lunchtime after UK gross domestic product (GDP) figures showed the country exit
Read more